1. Home
  2. JAGX vs BGMS Comparison

JAGX vs BGMS Comparison

Compare JAGX & BGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.41

Market Cap

5.0M

Sector

Health Care

ML Signal

HOLD

Logo Bio Green Med Solution Inc.

BGMS

Bio Green Med Solution Inc.

N/A

Current Price

$1.03

Market Cap

5.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
JAGX
BGMS
Founded
2013
1996
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.0M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
JAGX
BGMS
Price
$0.41
$1.03
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
358.4K
97.7K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$11,511,000.00
N/A
Revenue This Year
$22.41
N/A
Revenue Next Year
$30.00
$80,482.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.73
52 Week High
$15.48
$6.70

Technical Indicators

Market Signals
Indicator
JAGX
BGMS
Relative Strength Index (RSI) 41.38 49.85
Support Level N/A $0.74
Resistance Level $0.69 $1.13
Average True Range (ATR) 0.04 0.10
MACD 0.01 0.01
Stochastic Oscillator 43.75 49.84

Price Performance

Historical Comparison
JAGX
BGMS

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About BGMS Bio Green Med Solution Inc.

Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

Share on Social Networks: